Have a personal or library account? Click to login
The Evaluation of Determinants and Impacts of Co-Production in Healthcare: A Research Protocol for OPAT in Cystic Fibrosis Cover

The Evaluation of Determinants and Impacts of Co-Production in Healthcare: A Research Protocol for OPAT in Cystic Fibrosis

International Journal of Integrated Care
Volume 21 (2021): Issue 2
By: Marta Marsilio,  Andrea Gramegna,  Floriana Fusco,  Eleonora Gheduzzi,  Giovanna Pizzamiglio,  Francesco Blasi and  Chiara Guglielmetti  
Open Access
|Apr 2021

Figures & Tables

ijic-21-2-5568-g1.png
Figure 1

The study framework - an adapted version of COM-B Model.

ijic-21-2-5568-g2.png
Figure 2

Depiction of OPAT flow in the CF Centre.

ijic-21-2-5568-g3.png
Figure 3

The study target population.

Table 1

Inclusion and exclusion criteria for the participants.

SAMPLEINCLUSION CRITERIAEXCLUSION CRITERIA
Patients
(and their caregivers)

  • needed at least once intravenous antibiotic therapy;

  • in follow up at the adult unit for at least two years;

  • agree to participate in the study, by signing informed consent.

  • never required intravenous antibiotic therapy;

  • under transition process from paediatric to the adult unit or has been actively followed up in the adult unit for less than two years;

  • refuse to participate in the study.

Professionals (clinicians and hospital manager)

  • agree to participate in the study

  • refuse to participate in the study

Table 2

Aims, variables, and methods matrix.

AIMSSTUDY DESIGNVARIABLES (COM-B MODEL)METHODS

  1. The evaluation of the determinants and the impacts/outcomes of co-produced OPAT treatment compared to those of the traditional inpatient treatment

Cross-sectional study, comparing OPAT with inpatient therapy

  • – Determinants (Capability; Motivation; Opportunity)

  1. Content analysis of semi-structured interviews of patients, caregivers, and professionals;

  2. descriptive and inferential statistics on questionnaires administered to patients, caregivers and professionals;

  • – Performance (Clinical; Economic; Organisational)

  1. Content analysis of semi-structured interview of patients, caregivers, and professionals;

  2. descriptive and inferential statistics on questionnaires administered to patients, caregivers, and professionals;

  3. cost evaluation analysis;

  4. microbiome analysis;

  5. desk analysis on archival data

  • 2. The evaluation whether and how new procedure impacts on the dimensions and stakeholders of the model

Longitudinal study, comparing OPAT before and after new procedure

  • – Determinants (Capability; Motivation; Opportunity)

  1. Content analysis on semi-structured interview to OPAT patients, caregivers, and professionals;

  2. descriptive and inferential statistics on questionnaires administered to OPAT patients and professionals;

  • – Performance (Clinical; Economic; Organisational)

  1. Content analysis on semi-structured interview to OPAT patients and professionals;

  2. descriptive and inferential statistics on questionnaires administered to OPAT patients and professionals;

  3. cost evaluation analysis;

  4. desk analysis on archival data.

DOI: https://doi.org/10.5334/ijic.5568 | Journal eISSN: 1568-4156
Journal RSS Feed
Language: English
Submitted on: Jun 29, 2020
|
Accepted on: Feb 23, 2021
|
Published on: Apr 30, 2021
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
co-production,
evaluation,
impact,
determinants,
health,
OPAT,
cystic fibrosis

© 2021 Marta Marsilio, Andrea Gramegna, Floriana Fusco, Eleonora Gheduzzi, Giovanna Pizzamiglio, Francesco Blasi, Chiara Guglielmetti, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 21 (2021): Issue 2Next article